• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯毒素是一种源自蝎子的肽,它能特异性地与神经外胚层起源的胶质瘤和肿瘤结合。

Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.

作者信息

Lyons Susan A, O'Neal Jeffrey, Sontheimer Harald

机构信息

TransMolecular, Inc., Birmingham, Alabama 35294, USA.

出版信息

Glia. 2002 Aug;39(2):162-73. doi: 10.1002/glia.10083.

DOI:10.1002/glia.10083
PMID:12112367
Abstract

Highly migratory neuroectodermal cells share a common embryonic origin with cells of the central nervous system (CNS). They include enteric, parasympathetic, sympathoadrenal, and sensory neurons of the peripheral nervous system, Schwann cells, melanocytes, endocrine cells, and cells forming connective tissue of the face and neck. Because of their common embryologic origin, these cells and the tumors that derive from them can share genetic and antigenic phenotypes with gliomas, tumors derived from CNS glia. We recently discovered that chlorotoxin (ClTx), a 4-kD peptide purified from Leiurus quinquestriatus scorpion, is a highly specific marker for glioma cells in biopsy tissues (Soroceanu et al. Cancer Res 58:4871-4879, 1998) that can target tumors in animal models. We report on the specificity of ClTx as a marker for tumors of neuroectodermal origin that include peripheral neuroectodermal tumors (PNET) and gliomas. Specifically, we histochemically stained frozen and paraffin tissue sections of human biopsy tissues from 262 patients with a synthetically manufactured and biologically active ClTx bearing an N-terminal biotin. The vast majority (74 of 79) of primary human brain tumors investigated showed abundant binding of ClTx with greater than 90% ClTx-positive cells in each section. By comparison, 32 biopsies of uninvolved brain used for comparison were largely ClTx-negative, with only a few isolated reactive astrocytes showing some ClTx binding. However, as with gliomas, the vast majority of PNETs examined showed specific ClTx binding (31 of 34). These include medulloblastomas (4 of 4), neuroblastomas (6 of 7), ganglioneuromas (4 of 4), melanomas (7 of 7), adrenal pheochromocytomas (5 of 6), primitive PNET (1), small cell lung carcinoma (2 of 3), and Ewing's sarcoma (2 of 2). Under identical staining conditions, normal tissues from brain, skin, kidney, and lung were consistently negative for ClTx. These results suggest that chlorotoxin is a reliable and specific histopathological marker for tumors of neuroectodermal origin and that chlorotoxin derivatives with cytolytic activity may have therapeutic potential for these cancers.

摘要

高迁移性神经外胚层细胞与中枢神经系统(CNS)的细胞有着共同的胚胎起源。它们包括外周神经系统的肠神经元、副交感神经元、交感肾上腺神经元和感觉神经元、施万细胞、黑素细胞、内分泌细胞以及形成面部和颈部结缔组织的细胞。由于它们共同的胚胎学起源,这些细胞以及由它们衍生而来的肿瘤可与神经胶质瘤(源自CNS神经胶质的肿瘤)共享遗传和抗原表型。我们最近发现,从以色列金蝎中纯化得到的一种4-kD肽——氯毒素(ClTx),是活检组织中胶质瘤细胞的一种高度特异性标志物(Soroceanu等人,《癌症研究》58:4871 - 4879,1998年),它能够在动物模型中靶向肿瘤。我们报告了ClTx作为神经外胚层起源肿瘤标志物的特异性,这些肿瘤包括外周神经外胚层肿瘤(PNET)和神经胶质瘤。具体而言,我们用一种合成制造且具有生物活性、N端带有生物素的ClTx对262例患者的人活检组织的冷冻和石蜡组织切片进行了组织化学染色。在所研究的绝大多数(79例中的74例)原发性人脑肿瘤中,每个切片都显示ClTx有大量结合,ClTx阳性细胞超过90%。相比之下,用于对照的32例未受累脑活检组织大多为ClTx阴性,只有少数孤立的反应性星形胶质细胞显示出一些ClTx结合。然而,与神经胶质瘤一样,所检查的绝大多数PNET也显示出特异性的ClTx结合(34例中的31例)。这些肿瘤包括髓母细胞瘤(4例中的4例)、神经母细胞瘤(7例中的6例)、神经节神经瘤(4例中的4例)、黑色素瘤(7例中的7例)、肾上腺嗜铬细胞瘤(6例中的5例)、原始PNET(1例)、小细胞肺癌(3例中的2例)和尤因肉瘤(2例中的2例)。在相同的染色条件下,来自脑、皮肤、肾和肺的正常组织对ClTx始终呈阴性。这些结果表明,氯毒素是神经外胚层起源肿瘤可靠且特异的组织病理学标志物,具有细胞溶解活性的氯毒素衍生物可能对这些癌症具有治疗潜力。

相似文献

1
Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.氯毒素是一种源自蝎子的肽,它能特异性地与神经外胚层起源的胶质瘤和肿瘤结合。
Glia. 2002 Aug;39(2):162-73. doi: 10.1002/glia.10083.
2
Use of chlorotoxin for targeting of primary brain tumors.使用氯毒素靶向原发性脑肿瘤。
Cancer Res. 1998 Nov 1;58(21):4871-9.
3
A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma. Is there any role in disease process?软组织肉瘤以及原始神经外胚层肿瘤和尤因肉瘤中c-kit表达的一般情况。其在疾病进程中是否起作用?
Saudi Med J. 2005 Aug;26(8):1190-6.
4
Expression of type I interferon receptor in solid tumors of childhood.儿童实体瘤中I型干扰素受体的表达。
Mod Pathol. 1997 Jan;10(1):55-61.
5
Assessment of muscarinic and nicotinic acetylcholine receptor expression in primitive neuroectodermal tumor/ewing family of tumor and desmoplastic small round cell tumor: an immunohistochemical and Western blot study of tissue microarray and cell lines.原始神经外胚层肿瘤/尤因家族性肿瘤及促纤维增生性小圆细胞肿瘤中毒蕈碱型和烟碱型乙酰胆碱受体表达的评估:组织芯片和细胞系的免疫组织化学及蛋白质印迹研究
Fetal Pediatr Pathol. 2008;27(2):83-97. doi: 10.1080/15513810802077529.
6
Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.氯通道介导的氯毒素修饰的阿霉素脂质体靶向脑胶质瘤。
J Control Release. 2011 Jun 30;152(3):402-10. doi: 10.1016/j.jconrel.2011.03.014. Epub 2011 Mar 22.
7
Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.Fas(APO-1,CD95)受体表达与儿童髓母细胞瘤免疫治疗的新选择
Anticancer Res. 1999 Jul-Aug;19(4B):3293-314.
8
In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells.白蛋白-阿霉素偶联物对尤因肉瘤和外周神经外胚层肿瘤细胞的体外抗增殖作用。
Anticancer Res. 1994 Sep-Oct;14(5A):1943-50.
9
Secretogranin II expression in Ewing's sarcomas and primitive neuroectodermal tumors.分泌粒蛋白II在尤因肉瘤和原始神经外胚层肿瘤中的表达。
Diagn Mol Pathol. 1992 Sep;1(3):165-72.
10
Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.神经胶质分化预示着原始神经外胚层脑肿瘤的临床预后不良。
Ann Neurol. 1996 Apr;39(4):481-9. doi: 10.1002/ana.410390410.

引用本文的文献

1
Does chlorotoxin target matrix metalloproteinase-2 in glioblastoma?氯毒素是否作用于胶质母细胞瘤中的基质金属蛋白酶-2?
bioRxiv. 2025 Jul 16:2025.07.11.664294. doi: 10.1101/2025.07.11.664294.
2
Revolutionizing cancer treatment: an in-depth exploration of CAR-T cell therapies.颠覆癌症治疗:CAR-T 细胞疗法的深入探索。
Med Oncol. 2024 Oct 14;41(11):275. doi: 10.1007/s12032-024-02491-6.
3
Harnessing the potency of scorpion venom-derived proteins: applications in cancer therapy.利用蝎毒衍生蛋白的效力:在癌症治疗中的应用。
Bioresour Bioprocess. 2024 Oct 3;11(1):93. doi: 10.1186/s40643-024-00805-0.
4
Shining a Light on Venom-Peptide Receptors: Venom Peptides as Targeted Agents for In Vivo Molecular Imaging.揭示毒液肽受体的奥秘:毒液肽作为活体分子成像的靶向试剂。
Toxins (Basel). 2024 Jul 4;16(7):307. doi: 10.3390/toxins16070307.
5
Ferroptosis is an effective strategy for cancer therapy.铁死亡是一种有效的癌症治疗策略。
Med Oncol. 2024 Apr 23;41(5):124. doi: 10.1007/s12032-024-02317-5.
6
Novel Clinical Trials and Approaches in the Management of Glioblastoma.新型临床试验和方法在胶质母细胞瘤治疗中的应用。
Curr Oncol Rep. 2024 May;26(5):439-465. doi: 10.1007/s11912-024-01519-4. Epub 2024 Mar 28.
7
Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma.嵌合抗原受体T细胞疗法治疗胶质母细胞瘤
Cancers (Basel). 2023 Nov 30;15(23):5652. doi: 10.3390/cancers15235652.
8
Optimizing CAR-T Therapy for Glioblastoma.优化 CAR-T 疗法治疗脑胶质瘤。
Mol Diagn Ther. 2023 Nov;27(6):643-660. doi: 10.1007/s40291-023-00671-0. Epub 2023 Sep 12.
9
Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles.使用氯毒素纳米颗粒治疗胶质母细胞瘤和神经母细胞瘤癌症的诊断与治疗方法。
Cancers (Basel). 2023 Jun 28;15(13):3388. doi: 10.3390/cancers15133388.
10
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.基于分裂T7聚合酶构建雷帕霉素诱导型基因开关以调控溶瘤病毒驱动的肿瘤局部白细胞介素-12产生用于抗癌免疫治疗
Pharmaceuticals (Basel). 2023 May 7;16(5):709. doi: 10.3390/ph16050709.